Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lower Urinary Tract Symptoms | 19 | 2023 | 59 | 4.260 |
Why?
|
Chronic Pain | 15 | 2023 | 145 | 2.970 |
Why?
|
Depression | 20 | 2023 | 473 | 2.810 |
Why?
|
Pelvic Pain | 12 | 2023 | 80 | 2.240 |
Why?
|
Quality of Life | 15 | 2023 | 1585 | 2.200 |
Why?
|
Surveys and Questionnaires | 37 | 2022 | 2504 | 2.170 |
Why?
|
Memory, Episodic | 10 | 2018 | 54 | 2.170 |
Why?
|
Military Personnel | 4 | 2020 | 85 | 2.080 |
Why?
|
Cystitis, Interstitial | 8 | 2023 | 53 | 2.010 |
Why?
|
Stress, Psychological | 10 | 2019 | 313 | 1.680 |
Why?
|
Psychometrics | 18 | 2022 | 327 | 1.590 |
Why?
|
Dermatitis, Atopic | 4 | 2021 | 52 | 1.340 |
Why?
|
Anxiety | 11 | 2022 | 287 | 1.300 |
Why?
|
Prostatitis | 5 | 2023 | 13 | 1.290 |
Why?
|
Health Literacy | 4 | 2023 | 70 | 1.270 |
Why?
|
Stress Disorders, Post-Traumatic | 6 | 2018 | 96 | 1.160 |
Why?
|
Mental Recall | 4 | 2018 | 159 | 1.050 |
Why?
|
Adolescent | 42 | 2021 | 8984 | 1.020 |
Why?
|
Eczema | 2 | 2021 | 7 | 1.010 |
Why?
|
Depressive Disorder, Major | 6 | 2013 | 158 | 0.990 |
Why?
|
Taste Threshold | 3 | 2013 | 4 | 0.980 |
Why?
|
Male | 83 | 2023 | 40988 | 0.960 |
Why?
|
Suicide | 2 | 2016 | 139 | 0.930 |
Why?
|
Adult | 55 | 2023 | 25659 | 0.920 |
Why?
|
Self Report | 7 | 2020 | 288 | 0.920 |
Why?
|
Humans | 116 | 2023 | 86678 | 0.910 |
Why?
|
Female | 84 | 2023 | 44550 | 0.900 |
Why?
|
Pain Measurement | 6 | 2022 | 321 | 0.880 |
Why?
|
Anxiety Disorders | 9 | 2022 | 148 | 0.830 |
Why?
|
Vaccination | 1 | 2023 | 254 | 0.780 |
Why?
|
Symptom Assessment | 4 | 2019 | 65 | 0.770 |
Why?
|
Affect | 4 | 2021 | 386 | 0.760 |
Why?
|
Fear | 5 | 2023 | 78 | 0.750 |
Why?
|
Violence | 2 | 2020 | 143 | 0.750 |
Why?
|
Young Adult | 26 | 2020 | 5980 | 0.740 |
Why?
|
Psychology, Adolescent | 2 | 2011 | 29 | 0.730 |
Why?
|
Suicidal Ideation | 1 | 2020 | 67 | 0.730 |
Why?
|
Alzheimer Disease | 1 | 2023 | 470 | 0.710 |
Why?
|
Neurotic Disorders | 6 | 2011 | 13 | 0.710 |
Why?
|
Hydrocortisone | 3 | 2013 | 298 | 0.710 |
Why?
|
Taste Perception | 3 | 2013 | 4 | 0.680 |
Why?
|
Severity of Illness Index | 13 | 2021 | 1802 | 0.680 |
Why?
|
Middle Aged | 45 | 2023 | 25040 | 0.660 |
Why?
|
National Institutes of Health (U.S.) | 6 | 2015 | 122 | 0.650 |
Why?
|
Critical Illness | 1 | 2020 | 294 | 0.630 |
Why?
|
Urinary Incontinence, Stress | 4 | 2023 | 192 | 0.610 |
Why?
|
Urinary Bladder | 5 | 2022 | 246 | 0.590 |
Why?
|
Attitude | 3 | 2014 | 127 | 0.550 |
Why?
|
Factor Analysis, Statistical | 9 | 2019 | 111 | 0.520 |
Why?
|
Receptors, G-Protein-Coupled | 2 | 2013 | 115 | 0.520 |
Why?
|
Combat Disorders | 1 | 2015 | 4 | 0.520 |
Why?
|
Self Concept | 5 | 2018 | 133 | 0.520 |
Why?
|
Status Epilepticus | 2 | 2005 | 31 | 0.520 |
Why?
|
Hearing Loss | 5 | 2019 | 56 | 0.510 |
Why?
|
Reproducibility of Results | 15 | 2022 | 2706 | 0.510 |
Why?
|
Urinary Incontinence | 5 | 2022 | 206 | 0.510 |
Why?
|
Patient Acceptance of Health Care | 1 | 2017 | 238 | 0.510 |
Why?
|
Sleep Wake Disorders | 3 | 2022 | 115 | 0.500 |
Why?
|
Adolescent Behavior | 3 | 2011 | 106 | 0.500 |
Why?
|
Personality | 4 | 2019 | 134 | 0.500 |
Why?
|
Neuroprotective Agents | 2 | 2005 | 94 | 0.500 |
Why?
|
Aged | 31 | 2023 | 18423 | 0.500 |
Why?
|
Emotions | 5 | 2018 | 341 | 0.490 |
Why?
|
Candy | 1 | 2014 | 3 | 0.490 |
Why?
|
Cacao | 1 | 2014 | 4 | 0.490 |
Why?
|
Cross-Sectional Studies | 11 | 2023 | 1621 | 0.490 |
Why?
|
Social Support | 2 | 2015 | 193 | 0.480 |
Why?
|
Craving | 1 | 2014 | 21 | 0.480 |
Why?
|
Parenting | 1 | 2014 | 67 | 0.470 |
Why?
|
Resilience, Psychological | 2 | 2013 | 23 | 0.470 |
Why?
|
Propylthiouracil | 1 | 2013 | 24 | 0.460 |
Why?
|
Neuropsychological Tests | 3 | 2013 | 502 | 0.450 |
Why?
|
Depressive Disorder | 5 | 2014 | 218 | 0.450 |
Why?
|
Psychological Tests | 3 | 2017 | 91 | 0.450 |
Why?
|
Urinary Tract | 2 | 2023 | 34 | 0.440 |
Why?
|
Personal Satisfaction | 1 | 2013 | 62 | 0.440 |
Why?
|
Longitudinal Studies | 12 | 2022 | 1019 | 0.420 |
Why?
|
Stress Disorders, Traumatic, Acute | 1 | 2011 | 1 | 0.420 |
Why?
|
Saliva | 3 | 2013 | 122 | 0.420 |
Why?
|
Self-Injurious Behavior | 1 | 2014 | 105 | 0.420 |
Why?
|
Brain | 6 | 2020 | 2216 | 0.420 |
Why?
|
Patient Reported Outcome Measures | 5 | 2020 | 166 | 0.410 |
Why?
|
Crime Victims | 1 | 2011 | 34 | 0.400 |
Why?
|
Personality Development | 1 | 2011 | 23 | 0.400 |
Why?
|
Time Factors | 8 | 2021 | 5214 | 0.400 |
Why?
|
Prospective Studies | 15 | 2022 | 4214 | 0.390 |
Why?
|
United States | 17 | 2022 | 6681 | 0.390 |
Why?
|
Uracil | 1 | 2011 | 72 | 0.390 |
Why?
|
Child | 14 | 2023 | 6928 | 0.370 |
Why?
|
Predictive Value of Tests | 4 | 2017 | 1673 | 0.370 |
Why?
|
Urinary Incontinence, Urge | 3 | 2022 | 42 | 0.370 |
Why?
|
Cues | 4 | 2014 | 175 | 0.350 |
Why?
|
Wakefulness | 1 | 2010 | 134 | 0.350 |
Why?
|
Models, Psychological | 6 | 2018 | 157 | 0.340 |
Why?
|
Criminals | 2 | 2020 | 33 | 0.340 |
Why?
|
Diagnostic Self Evaluation | 2 | 2019 | 12 | 0.330 |
Why?
|
Cluster Analysis | 5 | 2022 | 369 | 0.330 |
Why?
|
Thinking | 3 | 2014 | 33 | 0.330 |
Why?
|
Health Status Indicators | 2 | 2019 | 105 | 0.320 |
Why?
|
Memory Disorders | 2 | 2023 | 69 | 0.320 |
Why?
|
Ear Diseases | 2 | 2019 | 19 | 0.320 |
Why?
|
Affective Symptoms | 3 | 2015 | 47 | 0.310 |
Why?
|
Biomedical Research | 3 | 2018 | 376 | 0.310 |
Why?
|
Risk Factors | 12 | 2019 | 5420 | 0.300 |
Why?
|
Prisoners | 2 | 2020 | 40 | 0.290 |
Why?
|
Pelvic Organ Prolapse | 2 | 2019 | 139 | 0.290 |
Why?
|
Hearing Aids | 4 | 2019 | 8 | 0.290 |
Why?
|
Child, Preschool | 9 | 2021 | 3613 | 0.290 |
Why?
|
Nitrogen Oxides | 1 | 2005 | 14 | 0.280 |
Why?
|
Eflornithine | 4 | 2007 | 11 | 0.270 |
Why?
|
Cognition | 5 | 2020 | 571 | 0.270 |
Why?
|
Free Radical Scavengers | 1 | 2005 | 59 | 0.270 |
Why?
|
Sex Factors | 7 | 2019 | 1055 | 0.270 |
Why?
|
Benzenesulfonates | 1 | 2005 | 66 | 0.270 |
Why?
|
Back Pain | 2 | 2016 | 42 | 0.260 |
Why?
|
Sleep | 4 | 2022 | 444 | 0.260 |
Why?
|
Amino Acids, Cyclic | 1 | 2004 | 1 | 0.250 |
Why?
|
Cycloserine | 1 | 2004 | 5 | 0.250 |
Why?
|
Antimetabolites | 1 | 2004 | 24 | 0.250 |
Why?
|
Receptors, Glycine | 1 | 2004 | 10 | 0.250 |
Why?
|
Kinesthesis | 2 | 2015 | 15 | 0.250 |
Why?
|
Prevalence | 4 | 2021 | 1239 | 0.250 |
Why?
|
Mental Disorders | 2 | 2018 | 371 | 0.240 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2004 | 87 | 0.240 |
Why?
|
Social Participation | 1 | 2023 | 14 | 0.240 |
Why?
|
Circadian Rhythm | 3 | 2013 | 303 | 0.240 |
Why?
|
Nocturia | 3 | 2019 | 19 | 0.230 |
Why?
|
Psychological Trauma | 1 | 2023 | 8 | 0.230 |
Why?
|
Boston | 1 | 2023 | 33 | 0.230 |
Why?
|
Pain Threshold | 1 | 2023 | 58 | 0.220 |
Why?
|
Cohort Studies | 8 | 2022 | 2768 | 0.220 |
Why?
|
Urination | 2 | 2020 | 37 | 0.220 |
Why?
|
Longevity | 2 | 2015 | 51 | 0.220 |
Why?
|
Urodynamics | 2 | 2020 | 122 | 0.220 |
Why?
|
Age Factors | 6 | 2018 | 1852 | 0.210 |
Why?
|
Waste Disposal, Fluid | 1 | 2002 | 2 | 0.210 |
Why?
|
Sewage | 1 | 2002 | 3 | 0.210 |
Why?
|
Environmental Pollution | 1 | 2002 | 13 | 0.210 |
Why?
|
Polyamines | 3 | 2007 | 32 | 0.210 |
Why?
|
Low Back Pain | 1 | 2022 | 40 | 0.210 |
Why?
|
Fracture Healing | 1 | 2021 | 34 | 0.200 |
Why?
|
Personality Inventory | 4 | 2010 | 108 | 0.200 |
Why?
|
Chicago | 3 | 2023 | 1380 | 0.200 |
Why?
|
Urinary Bladder, Overactive | 1 | 2022 | 87 | 0.200 |
Why?
|
Reflex, Startle | 2 | 2014 | 32 | 0.200 |
Why?
|
Hip Fractures | 1 | 2021 | 45 | 0.200 |
Why?
|
Pelvic Floor Disorders | 2 | 2019 | 55 | 0.200 |
Why?
|
Iraq War, 2003-2011 | 1 | 2020 | 3 | 0.200 |
Why?
|
Food Preferences | 2 | 2011 | 26 | 0.200 |
Why?
|
Afghan Campaign 2001- | 1 | 2020 | 4 | 0.200 |
Why?
|
Absorptiometry, Photon | 2 | 2019 | 99 | 0.190 |
Why?
|
Nervous System Physiological Phenomena | 1 | 2020 | 17 | 0.190 |
Why?
|
Magnetic Resonance Imaging | 5 | 2020 | 3362 | 0.190 |
Why?
|
Schools | 1 | 2021 | 71 | 0.190 |
Why?
|
Personality Assessment | 2 | 2011 | 98 | 0.190 |
Why?
|
Burnout, Professional | 1 | 2022 | 94 | 0.190 |
Why?
|
Patient Participation | 2 | 2019 | 216 | 0.190 |
Why?
|
Psychiatric Status Rating Scales | 6 | 2013 | 487 | 0.180 |
Why?
|
Bone Density | 2 | 2019 | 209 | 0.180 |
Why?
|
Educational Status | 1 | 2020 | 190 | 0.180 |
Why?
|
Skin Diseases | 1 | 2021 | 166 | 0.180 |
Why?
|
Mobile Applications | 1 | 2021 | 63 | 0.180 |
Why?
|
General Practitioners | 1 | 2019 | 12 | 0.180 |
Why?
|
Self-Management | 1 | 2020 | 29 | 0.180 |
Why?
|
Video Games | 1 | 2019 | 11 | 0.180 |
Why?
|
Pandemics | 2 | 2023 | 740 | 0.180 |
Why?
|
Neuroimaging | 1 | 2020 | 113 | 0.180 |
Why?
|
Genotype | 4 | 2013 | 1852 | 0.180 |
Why?
|
Health Promotion | 1 | 2021 | 160 | 0.170 |
Why?
|
Urinary Bladder Diseases | 1 | 2019 | 41 | 0.170 |
Why?
|
Scoliosis | 1 | 2019 | 31 | 0.170 |
Why?
|
Rats, Sprague-Dawley | 5 | 2021 | 1221 | 0.170 |
Why?
|
Intracellular Space | 1 | 2019 | 38 | 0.170 |
Why?
|
Myosin-Light-Chain Kinase | 1 | 2019 | 41 | 0.170 |
Why?
|
Hearing Tests | 1 | 2018 | 10 | 0.170 |
Why?
|
Logistic Models | 4 | 2017 | 1188 | 0.170 |
Why?
|
Activities of Daily Living | 1 | 2020 | 204 | 0.170 |
Why?
|
Education, Medical, Continuing | 1 | 2019 | 107 | 0.170 |
Why?
|
Contraindications | 1 | 2018 | 72 | 0.170 |
Why?
|
Rumination, Cognitive | 1 | 2018 | 1 | 0.160 |
Why?
|
Feasibility Studies | 1 | 2020 | 751 | 0.160 |
Why?
|
Interpersonal Relations | 2 | 2011 | 170 | 0.160 |
Why?
|
Syndrome | 4 | 2022 | 446 | 0.160 |
Why?
|
Teaching | 1 | 2019 | 147 | 0.160 |
Why?
|
Mice, Inbred DBA | 4 | 2015 | 148 | 0.160 |
Why?
|
Disease Progression | 5 | 2015 | 1532 | 0.160 |
Why?
|
Placebos | 1 | 2018 | 218 | 0.160 |
Why?
|
Fecal Incontinence | 1 | 2018 | 57 | 0.160 |
Why?
|
Cognitive Dysfunction | 1 | 2020 | 132 | 0.160 |
Why?
|
Bone and Bones | 1 | 2019 | 265 | 0.160 |
Why?
|
Sensitivity and Specificity | 4 | 2019 | 1992 | 0.150 |
Why?
|
Connectome | 1 | 2018 | 74 | 0.150 |
Why?
|
Sexual Dysfunction, Physiological | 1 | 2018 | 67 | 0.150 |
Why?
|
Catastrophization | 1 | 2017 | 7 | 0.150 |
Why?
|
Femur Neck | 2 | 2019 | 44 | 0.150 |
Why?
|
Health Services Accessibility | 2 | 2019 | 394 | 0.150 |
Why?
|
Chromosomes, Mammalian | 2 | 2015 | 36 | 0.150 |
Why?
|
Evidence-Based Medicine | 1 | 2019 | 429 | 0.150 |
Why?
|
Association Learning | 2 | 2014 | 34 | 0.150 |
Why?
|
Motivation | 1 | 2019 | 288 | 0.150 |
Why?
|
Homeostasis | 1 | 2019 | 409 | 0.150 |
Why?
|
Sleep Apnea Syndromes | 1 | 2018 | 103 | 0.150 |
Why?
|
Quantitative Trait Loci | 3 | 2010 | 577 | 0.140 |
Why?
|
Self Care | 1 | 2018 | 164 | 0.140 |
Why?
|
Adaptation, Psychological | 2 | 2015 | 157 | 0.140 |
Why?
|
Nerve Net | 2 | 2019 | 366 | 0.140 |
Why?
|
Mood Disorders | 2 | 2014 | 81 | 0.140 |
Why?
|
Qualitative Research | 1 | 2017 | 256 | 0.140 |
Why?
|
Rats | 5 | 2021 | 3992 | 0.140 |
Why?
|
Pain | 2 | 2021 | 391 | 0.140 |
Why?
|
Aged, 80 and over | 6 | 2015 | 6513 | 0.140 |
Why?
|
Amygdala | 1 | 2016 | 84 | 0.130 |
Why?
|
Touch | 2 | 2015 | 89 | 0.130 |
Why?
|
Chronic Disease | 4 | 2022 | 973 | 0.130 |
Why?
|
Pilocarpine | 2 | 2005 | 7 | 0.130 |
Why?
|
Firearms | 1 | 2016 | 49 | 0.130 |
Why?
|
Nervous System Diseases | 1 | 2016 | 151 | 0.130 |
Why?
|
Colorectal Neoplasms | 1 | 2023 | 938 | 0.130 |
Why?
|
Phobic Disorders | 2 | 2014 | 13 | 0.130 |
Why?
|
Lithium | 2 | 2005 | 59 | 0.130 |
Why?
|
Diagnostic Errors | 1 | 2016 | 160 | 0.130 |
Why?
|
White Matter | 1 | 2016 | 80 | 0.130 |
Why?
|
Executive Function | 2 | 2018 | 86 | 0.130 |
Why?
|
Self Efficacy | 1 | 2015 | 53 | 0.130 |
Why?
|
Patient Care Team | 2 | 2015 | 280 | 0.130 |
Why?
|
Prefrontal Cortex | 1 | 2016 | 130 | 0.130 |
Why?
|
Aggression | 1 | 2018 | 320 | 0.130 |
Why?
|
Sucrose | 2 | 2013 | 64 | 0.120 |
Why?
|
Ambulatory Care Facilities | 1 | 2015 | 103 | 0.120 |
Why?
|
Animals | 17 | 2021 | 26590 | 0.120 |
Why?
|
Guilt | 1 | 2014 | 11 | 0.120 |
Why?
|
Behavioral Symptoms | 1 | 2014 | 15 | 0.120 |
Why?
|
Interview, Psychological | 2 | 2011 | 69 | 0.120 |
Why?
|
Health Behavior | 1 | 2015 | 183 | 0.120 |
Why?
|
Touch Perception | 1 | 2015 | 48 | 0.120 |
Why?
|
Intestinal Mucosa | 1 | 2019 | 797 | 0.120 |
Why?
|
Awareness | 1 | 2014 | 93 | 0.120 |
Why?
|
Dyspareunia | 1 | 2013 | 19 | 0.120 |
Why?
|
Noise | 1 | 2013 | 27 | 0.110 |
Why?
|
Taste | 1 | 2013 | 28 | 0.110 |
Why?
|
Irritable Bowel Syndrome | 1 | 2013 | 45 | 0.110 |
Why?
|
Tongue | 1 | 2013 | 57 | 0.110 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2017 | 508 | 0.110 |
Why?
|
Dysmenorrhea | 1 | 2013 | 49 | 0.110 |
Why?
|
Arteritis | 1 | 2012 | 9 | 0.110 |
Why?
|
Hippocampus | 1 | 2016 | 442 | 0.110 |
Why?
|
Calcaneus | 1 | 2012 | 34 | 0.110 |
Why?
|
Auditory Perception | 1 | 2013 | 96 | 0.110 |
Why?
|
Hip Joint | 1 | 2012 | 55 | 0.100 |
Why?
|
Spinal Cord Injuries | 1 | 2012 | 54 | 0.100 |
Why?
|
Heart-Assist Devices | 2 | 2012 | 731 | 0.100 |
Why?
|
Eosinophilia | 1 | 2012 | 84 | 0.100 |
Why?
|
Mice, Inbred C57BL | 4 | 2015 | 3095 | 0.100 |
Why?
|
Parents | 1 | 2014 | 272 | 0.100 |
Why?
|
Pruritus | 2 | 2021 | 26 | 0.100 |
Why?
|
Multimedia | 1 | 2011 | 9 | 0.100 |
Why?
|
Feeding Behavior | 1 | 2014 | 324 | 0.100 |
Why?
|
Osteoporosis | 1 | 2012 | 121 | 0.100 |
Why?
|
Electroencephalography | 2 | 2005 | 709 | 0.100 |
Why?
|
Medical Informatics | 1 | 2011 | 47 | 0.090 |
Why?
|
Smoking | 1 | 2014 | 609 | 0.090 |
Why?
|
Sex Characteristics | 4 | 2019 | 319 | 0.090 |
Why?
|
Aging | 1 | 2015 | 691 | 0.090 |
Why?
|
Body Mass Index | 1 | 2014 | 770 | 0.090 |
Why?
|
Pituitary-Adrenal Function Tests | 1 | 2010 | 2 | 0.090 |
Why?
|
Language | 2 | 2022 | 151 | 0.090 |
Why?
|
Rest | 2 | 2020 | 48 | 0.090 |
Why?
|
Risk Assessment | 4 | 2019 | 2264 | 0.090 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2019 | 1375 | 0.090 |
Why?
|
User-Computer Interface | 1 | 2011 | 185 | 0.090 |
Why?
|
Educational Measurement | 1 | 2011 | 226 | 0.080 |
Why?
|
Personality Tests | 1 | 2008 | 21 | 0.080 |
Why?
|
Phenotype | 2 | 2014 | 2380 | 0.080 |
Why?
|
Health | 1 | 2008 | 29 | 0.080 |
Why?
|
Corneal Neovascularization | 1 | 2008 | 1 | 0.080 |
Why?
|
Culture | 1 | 2008 | 53 | 0.080 |
Why?
|
Granulation Tissue | 1 | 2008 | 15 | 0.080 |
Why?
|
Mice | 9 | 2019 | 11356 | 0.080 |
Why?
|
Blood Pressure | 2 | 2012 | 1144 | 0.070 |
Why?
|
National Institute of Diabetes and Digestive and Kidney Diseases (U.S.) | 2 | 2018 | 5 | 0.070 |
Why?
|
Neoplasm Metastasis | 3 | 2007 | 1056 | 0.070 |
Why?
|
Anti-Bacterial Agents | 1 | 2012 | 747 | 0.070 |
Why?
|
Data Interpretation, Statistical | 1 | 2008 | 297 | 0.070 |
Why?
|
Mammary Neoplasms, Animal | 1 | 2007 | 54 | 0.070 |
Why?
|
Health Status | 2 | 2020 | 360 | 0.070 |
Why?
|
Naltrexone | 1 | 2008 | 135 | 0.070 |
Why?
|
Narcotic Antagonists | 1 | 2008 | 154 | 0.070 |
Why?
|
Follow-Up Studies | 4 | 2015 | 3642 | 0.070 |
Why?
|
Models, Statistical | 1 | 2010 | 575 | 0.070 |
Why?
|
Heart Rate | 1 | 2008 | 492 | 0.070 |
Why?
|
Cottontail rabbit papillomavirus | 1 | 2005 | 1 | 0.070 |
Why?
|
Cyclic N-Oxides | 1 | 2005 | 33 | 0.070 |
Why?
|
Materials Testing | 1 | 2006 | 91 | 0.070 |
Why?
|
Y Chromosome | 1 | 2005 | 28 | 0.070 |
Why?
|
Interdisciplinary Communication | 2 | 2018 | 130 | 0.070 |
Why?
|
Mouth Diseases | 1 | 2005 | 15 | 0.070 |
Why?
|
Alkaline Phosphatase | 1 | 2005 | 132 | 0.070 |
Why?
|
Lumbar Vertebrae | 2 | 2019 | 148 | 0.070 |
Why?
|
Neural Pathways | 2 | 2019 | 308 | 0.070 |
Why?
|
Warfare | 1 | 2005 | 10 | 0.060 |
Why?
|
Family Therapy | 1 | 2005 | 16 | 0.060 |
Why?
|
Psychotherapy, Group | 1 | 2005 | 33 | 0.060 |
Why?
|
Muscarinic Agonists | 1 | 2004 | 23 | 0.060 |
Why?
|
Parasympathetic Nervous System | 1 | 2004 | 33 | 0.060 |
Why?
|
Mass Screening | 2 | 2019 | 619 | 0.060 |
Why?
|
Schizophrenic Psychology | 1 | 2005 | 129 | 0.060 |
Why?
|
Biocompatible Materials | 1 | 2006 | 193 | 0.060 |
Why?
|
Comorbidity | 3 | 2018 | 944 | 0.060 |
Why?
|
Brain Mapping | 2 | 2019 | 549 | 0.060 |
Why?
|
Electrodes, Implanted | 1 | 2004 | 171 | 0.060 |
Why?
|
Lung Neoplasms | 3 | 2007 | 2262 | 0.060 |
Why?
|
Regression Analysis | 2 | 2018 | 596 | 0.060 |
Why?
|
Reactive Oxygen Species | 1 | 2005 | 480 | 0.060 |
Why?
|
ROC Curve | 2 | 2017 | 752 | 0.050 |
Why?
|
Multicenter Studies as Topic | 1 | 2022 | 159 | 0.050 |
Why?
|
Workplace | 1 | 2022 | 27 | 0.050 |
Why?
|
Placebo Effect | 1 | 2022 | 31 | 0.050 |
Why?
|
Naproxen | 1 | 2022 | 13 | 0.050 |
Why?
|
Enkephalin, Methionine | 1 | 2002 | 5 | 0.050 |
Why?
|
Prognosis | 3 | 2017 | 3680 | 0.050 |
Why?
|
Weaning | 1 | 2002 | 25 | 0.050 |
Why?
|
Time and Motion Studies | 1 | 2021 | 21 | 0.050 |
Why?
|
Motor Activity | 1 | 2004 | 327 | 0.050 |
Why?
|
Disease Models, Animal | 2 | 2005 | 2231 | 0.050 |
Why?
|
Postural Balance | 1 | 2021 | 42 | 0.050 |
Why?
|
Pregnancy, Animal | 1 | 2002 | 58 | 0.050 |
Why?
|
Pelvis | 1 | 2022 | 95 | 0.050 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2003 | 124 | 0.050 |
Why?
|
Patient Education as Topic | 1 | 2005 | 351 | 0.050 |
Why?
|
Vibration | 1 | 2021 | 49 | 0.050 |
Why?
|
Phosphorylation | 2 | 2019 | 1106 | 0.050 |
Why?
|
Electronics | 1 | 2021 | 15 | 0.050 |
Why?
|
Neoplasm Transplantation | 3 | 2007 | 391 | 0.050 |
Why?
|
Schizophrenia | 1 | 2005 | 464 | 0.050 |
Why?
|
Conservation of Natural Resources | 1 | 2002 | 79 | 0.050 |
Why?
|
Oxidation-Reduction | 1 | 2002 | 373 | 0.050 |
Why?
|
Proof of Concept Study | 1 | 2020 | 38 | 0.050 |
Why?
|
Chromosome Mapping | 3 | 2010 | 1074 | 0.050 |
Why?
|
Algorithms | 2 | 2019 | 1830 | 0.050 |
Why?
|
Criminal Behavior | 1 | 2020 | 3 | 0.050 |
Why?
|
Psychomotor Performance | 2 | 2015 | 492 | 0.050 |
Why?
|
Proteomics | 1 | 2022 | 211 | 0.050 |
Why?
|
Narration | 1 | 2020 | 16 | 0.050 |
Why?
|
Information Systems | 1 | 2020 | 29 | 0.050 |
Why?
|
Temperature | 1 | 2002 | 396 | 0.050 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2002 | 153 | 0.050 |
Why?
|
Animals, Newborn | 1 | 2002 | 510 | 0.050 |
Why?
|
Primary Health Care | 1 | 2004 | 339 | 0.050 |
Why?
|
Actigraphy | 1 | 2020 | 51 | 0.050 |
Why?
|
Water | 1 | 2002 | 277 | 0.050 |
Why?
|
Crime | 1 | 2020 | 36 | 0.050 |
Why?
|
Health Personnel | 1 | 2022 | 202 | 0.050 |
Why?
|
Kyphosis | 1 | 2019 | 14 | 0.040 |
Why?
|
Enzyme Inhibitors | 1 | 2003 | 639 | 0.040 |
Why?
|
Radius | 1 | 2019 | 29 | 0.040 |
Why?
|
Preoperative Period | 1 | 2019 | 91 | 0.040 |
Why?
|
Health Surveys | 1 | 2020 | 239 | 0.040 |
Why?
|
Delphi Technique | 1 | 2019 | 80 | 0.040 |
Why?
|
Myosin Light Chains | 1 | 2019 | 29 | 0.040 |
Why?
|
Finite Element Analysis | 1 | 2019 | 74 | 0.040 |
Why?
|
Urination Disorders | 1 | 2019 | 50 | 0.040 |
Why?
|
Caco-2 Cells | 1 | 2019 | 123 | 0.040 |
Why?
|
Jejunum | 1 | 2019 | 79 | 0.040 |
Why?
|
Cattle | 2 | 2012 | 376 | 0.040 |
Why?
|
Poland | 1 | 2018 | 17 | 0.040 |
Why?
|
Small Molecule Libraries | 1 | 2019 | 61 | 0.040 |
Why?
|
Actomyosin | 1 | 2019 | 46 | 0.040 |
Why?
|
Protein Domains | 1 | 2019 | 128 | 0.040 |
Why?
|
Femur | 1 | 2019 | 116 | 0.040 |
Why?
|
Government Regulation | 1 | 2018 | 49 | 0.040 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2004 | 1204 | 0.040 |
Why?
|
Treatment Outcome | 2 | 2022 | 7998 | 0.040 |
Why?
|
Physical Fitness | 1 | 2018 | 51 | 0.040 |
Why?
|
Gynecologic Surgical Procedures | 1 | 2019 | 135 | 0.040 |
Why?
|
United States Food and Drug Administration | 1 | 2018 | 127 | 0.040 |
Why?
|
Tight Junctions | 1 | 2019 | 149 | 0.040 |
Why?
|
Crosses, Genetic | 2 | 2010 | 171 | 0.040 |
Why?
|
Consensus | 1 | 2019 | 336 | 0.040 |
Why?
|
Constipation | 1 | 2018 | 63 | 0.040 |
Why?
|
Health Services Needs and Demand | 1 | 2018 | 102 | 0.040 |
Why?
|
Diarrhea | 1 | 2018 | 182 | 0.040 |
Why?
|
Socioeconomic Factors | 1 | 2019 | 567 | 0.040 |
Why?
|
Mental Health | 1 | 2018 | 162 | 0.040 |
Why?
|
Prosthesis Fitting | 1 | 2016 | 16 | 0.040 |
Why?
|
Oxygen | 1 | 2002 | 726 | 0.040 |
Why?
|
Interviews as Topic | 1 | 2018 | 319 | 0.040 |
Why?
|
Ear Neoplasms | 1 | 2016 | 10 | 0.040 |
Why?
|
Urology | 1 | 2018 | 110 | 0.040 |
Why?
|
Delivery of Health Care | 1 | 2021 | 426 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2003 | 1313 | 0.040 |
Why?
|
Functional Neuroimaging | 1 | 2016 | 32 | 0.040 |
Why?
|
Retrospective Studies | 3 | 2018 | 8496 | 0.030 |
Why?
|
Cell Line, Tumor | 3 | 2007 | 2426 | 0.030 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 2 | 2010 | 216 | 0.030 |
Why?
|
Cost-Benefit Analysis | 1 | 2018 | 455 | 0.030 |
Why?
|
Diffusion Tensor Imaging | 1 | 2016 | 67 | 0.030 |
Why?
|
Calibration | 1 | 2016 | 99 | 0.030 |
Why?
|
STAT3 Transcription Factor | 2 | 2007 | 78 | 0.030 |
Why?
|
Central Nervous System Neoplasms | 1 | 2016 | 81 | 0.030 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 2 | 2007 | 113 | 0.030 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2019 | 683 | 0.030 |
Why?
|
Intracranial Hemorrhages | 1 | 2016 | 120 | 0.030 |
Why?
|
Multivariate Analysis | 1 | 2018 | 1001 | 0.030 |
Why?
|
Double-Blind Method | 1 | 2019 | 1824 | 0.030 |
Why?
|
Infant | 1 | 2021 | 3047 | 0.030 |
Why?
|
Proprioception | 1 | 2015 | 32 | 0.030 |
Why?
|
Test Anxiety Scale | 1 | 2014 | 2 | 0.030 |
Why?
|
Anthracenes | 1 | 2014 | 16 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2018 | 865 | 0.030 |
Why?
|
Prodromal Symptoms | 1 | 2014 | 2 | 0.030 |
Why?
|
Discrimination Learning | 1 | 2014 | 63 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2018 | 1807 | 0.030 |
Why?
|
Germany, East | 1 | 2013 | 1 | 0.030 |
Why?
|
Germany, West | 1 | 2013 | 4 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2014 | 193 | 0.030 |
Why?
|
Incidence | 1 | 2018 | 1578 | 0.030 |
Why?
|
Genetic Linkage | 1 | 2015 | 623 | 0.030 |
Why?
|
Acoustic Impedance Tests | 1 | 2013 | 3 | 0.030 |
Why?
|
Inflammation | 1 | 2019 | 923 | 0.030 |
Why?
|
Quinine | 1 | 2013 | 6 | 0.030 |
Why?
|
Politics | 1 | 2013 | 50 | 0.030 |
Why?
|
Pituitary-Adrenal System | 1 | 2013 | 64 | 0.030 |
Why?
|
Audiometry, Pure-Tone | 1 | 2013 | 25 | 0.030 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2013 | 81 | 0.030 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2019 | 549 | 0.030 |
Why?
|
Kidney Cortex | 1 | 2012 | 33 | 0.030 |
Why?
|
Infarction | 1 | 2012 | 26 | 0.030 |
Why?
|
beta-Lactams | 1 | 2012 | 14 | 0.030 |
Why?
|
Databases, Factual | 1 | 2016 | 816 | 0.030 |
Why?
|
Residence Characteristics | 1 | 2014 | 197 | 0.030 |
Why?
|
Leukocyte Count | 1 | 2012 | 220 | 0.030 |
Why?
|
Smoking Cessation | 1 | 2014 | 230 | 0.030 |
Why?
|
Mice, Nude | 2 | 2005 | 790 | 0.030 |
Why?
|
Los Angeles | 1 | 2011 | 28 | 0.030 |
Why?
|
Lung | 2 | 2012 | 1169 | 0.030 |
Why?
|
Alleles | 1 | 2015 | 1128 | 0.030 |
Why?
|
Life Change Events | 1 | 2011 | 48 | 0.030 |
Why?
|
Eosinophils | 1 | 2012 | 194 | 0.030 |
Why?
|
Word Association Tests | 1 | 2011 | 5 | 0.020 |
Why?
|
Stroop Test | 1 | 2011 | 9 | 0.020 |
Why?
|
Psychological Theory | 1 | 2011 | 22 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2005 | 2903 | 0.020 |
Why?
|
Research Design | 1 | 2014 | 594 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2018 | 1037 | 0.020 |
Why?
|
Pulmonary Artery | 1 | 2012 | 306 | 0.020 |
Why?
|
Dependent Personality Disorder | 1 | 2009 | 1 | 0.020 |
Why?
|
Psychopathology | 1 | 2010 | 29 | 0.020 |
Why?
|
Lod Score | 1 | 2010 | 152 | 0.020 |
Why?
|
Breeding | 1 | 2010 | 39 | 0.020 |
Why?
|
Cell Proliferation | 2 | 2007 | 1579 | 0.020 |
Why?
|
Ultrasonography | 1 | 2012 | 695 | 0.020 |
Why?
|
Linear Models | 1 | 2011 | 422 | 0.020 |
Why?
|
Body Weight | 1 | 2011 | 459 | 0.020 |
Why?
|
Personal Autonomy | 1 | 2009 | 112 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2019 | 2601 | 0.020 |
Why?
|
Galvanic Skin Response | 1 | 2008 | 12 | 0.020 |
Why?
|
Social Adjustment | 1 | 2008 | 46 | 0.020 |
Why?
|
Pediatrics | 1 | 2013 | 344 | 0.020 |
Why?
|
Achievement | 1 | 2008 | 29 | 0.020 |
Why?
|
Blinking | 1 | 2008 | 17 | 0.020 |
Why?
|
Internal-External Control | 1 | 2008 | 44 | 0.020 |
Why?
|
Registries | 1 | 2012 | 703 | 0.020 |
Why?
|
Fluorophotometry | 1 | 2008 | 3 | 0.020 |
Why?
|
Mice, Inbred Strains | 1 | 2008 | 307 | 0.020 |
Why?
|
Epistasis, Genetic | 1 | 2008 | 86 | 0.020 |
Why?
|
Ophthalmic Solutions | 1 | 2008 | 16 | 0.020 |
Why?
|
Epithelium, Corneal | 1 | 2008 | 12 | 0.020 |
Why?
|
Administration, Topical | 1 | 2008 | 95 | 0.020 |
Why?
|
Acoustic Stimulation | 1 | 2008 | 130 | 0.020 |
Why?
|
Debridement | 1 | 2008 | 56 | 0.020 |
Why?
|
Memory | 1 | 2010 | 225 | 0.020 |
Why?
|
Electric Stimulation | 1 | 2008 | 347 | 0.020 |
Why?
|
Muscle Contraction | 1 | 2008 | 284 | 0.020 |
Why?
|
Reference Values | 1 | 2008 | 674 | 0.020 |
Why?
|
Stroke | 1 | 2016 | 965 | 0.020 |
Why?
|
Putrescine | 1 | 2006 | 6 | 0.020 |
Why?
|
Spermidine | 1 | 2006 | 6 | 0.020 |
Why?
|
Spermine | 1 | 2006 | 18 | 0.020 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2008 | 191 | 0.020 |
Why?
|
Stress, Physiological | 1 | 2008 | 227 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2012 | 1169 | 0.020 |
Why?
|
Ki-67 Antigen | 1 | 2006 | 64 | 0.020 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2007 | 125 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 115 | 0.020 |
Why?
|
Laminin | 1 | 2006 | 85 | 0.020 |
Why?
|
Drug Combinations | 1 | 2006 | 224 | 0.020 |
Why?
|
Proteoglycans | 1 | 2006 | 121 | 0.020 |
Why?
|
Polyurethanes | 1 | 2006 | 10 | 0.020 |
Why?
|
Titanium | 1 | 2006 | 20 | 0.020 |
Why?
|
Spectroscopy, Fourier Transform Infrared | 1 | 2006 | 30 | 0.020 |
Why?
|
Kidney | 1 | 2012 | 1242 | 0.020 |
Why?
|
Biomedical Engineering | 1 | 2006 | 20 | 0.020 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2006 | 135 | 0.020 |
Why?
|
Capsid | 1 | 2005 | 34 | 0.020 |
Why?
|
Wound Healing | 1 | 2008 | 344 | 0.020 |
Why?
|
Evaluation Studies as Topic | 1 | 2006 | 274 | 0.020 |
Why?
|
Surface Properties | 1 | 2006 | 130 | 0.020 |
Why?
|
Tunica Intima | 1 | 2006 | 59 | 0.020 |
Why?
|
In Vitro Techniques | 1 | 2007 | 989 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2008 | 449 | 0.020 |
Why?
|
Yugoslavia | 1 | 2005 | 1 | 0.020 |
Why?
|
Amidines | 1 | 2005 | 2 | 0.020 |
Why?
|
Collagen | 1 | 2006 | 269 | 0.020 |
Why?
|
STAT1 Transcription Factor | 1 | 2005 | 52 | 0.020 |
Why?
|
Indans | 1 | 2005 | 31 | 0.020 |
Why?
|
Equipment Design | 1 | 2006 | 407 | 0.020 |
Why?
|
DNA Primers | 1 | 2005 | 543 | 0.020 |
Why?
|
Mental Health Services | 1 | 2005 | 48 | 0.020 |
Why?
|
Rabbits | 1 | 2005 | 636 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2006 | 1047 | 0.020 |
Why?
|
Antineoplastic Agents | 2 | 2006 | 2360 | 0.020 |
Why?
|
Blood Glucose | 1 | 2008 | 873 | 0.010 |
Why?
|
Cell Death | 1 | 2005 | 256 | 0.010 |
Why?
|
Antipsychotic Agents | 1 | 2005 | 123 | 0.010 |
Why?
|
Cooperative Behavior | 1 | 2005 | 175 | 0.010 |
Why?
|
Patient Compliance | 1 | 2005 | 228 | 0.010 |
Why?
|
Ornithine Decarboxylase Inhibitors | 1 | 2003 | 2 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2005 | 552 | 0.010 |
Why?
|
Thrombosis | 1 | 2006 | 296 | 0.010 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2008 | 568 | 0.010 |
Why?
|
Luminescent Proteins | 1 | 2003 | 144 | 0.010 |
Why?
|
Opioid Peptides | 1 | 2002 | 5 | 0.010 |
Why?
|
Litter Size | 1 | 2002 | 12 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2010 | 1621 | 0.010 |
Why?
|
Fetal Death | 1 | 2002 | 56 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2003 | 305 | 0.010 |
Why?
|
Labor, Obstetric | 1 | 2002 | 46 | 0.010 |
Why?
|
Maternal Exposure | 1 | 2002 | 57 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2003 | 363 | 0.010 |
Why?
|
Base Sequence | 1 | 2005 | 2330 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2005 | 1753 | 0.010 |
Why?
|
Patient Readmission | 1 | 2005 | 329 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2003 | 1041 | 0.010 |
Why?
|
Organ Size | 1 | 2002 | 364 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2005 | 1686 | 0.010 |
Why?
|
Recurrence | 1 | 2004 | 1139 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2008 | 2357 | 0.010 |
Why?
|
Apoptosis | 1 | 2006 | 1683 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2005 | 1376 | 0.010 |
Why?
|
Pregnancy | 1 | 2002 | 2894 | 0.010 |
Why?
|